ID

34616

Description

A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25308); ODM derived from: https://clinicaltrials.gov/show/NCT01192880

Link

https://clinicaltrials.gov/show/NCT01192880

Keywords

  1. 1/19/19 1/19/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Schizophrenia NCT01192880

Eligibility Schizophrenia NCT01192880

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, aged 18 years and above
Description

Adult | Age

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
diagnosis of schizophrenia of paranoid, disorganized, residual, undifferentiated or catatonic subtype
Description

Paranoid Schizophrenia | Schizophrenia, Disorganized | Residual schizophrenia | Undifferentiated schizophrenia | Schizophrenia, Catatonic

Data type

boolean

Alias
UMLS CUI [1]
C0036349
UMLS CUI [2]
C0036347
UMLS CUI [3]
C0036351
UMLS CUI [4]
C0392322
UMLS CUI [5]
C0036344
predominant negative symptoms
Description

Symptoms Negative Primary

Data type

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C1513916
UMLS CUI [1,3]
C0205225
with the exception of clozapine, patients are on any of the available marketed atypical or typical antipsychotics (treatment with a maximum of two antipsychotics)
Description

Exception Clozapine | Atypical antipsychotic Quantity | Typical Antipsychotic Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1705847
UMLS CUI [1,2]
C0009079
UMLS CUI [2,1]
C1276996
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C2917392
UMLS CUI [3,2]
C1265611
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence that patient has clinically significant, uncontrolled and unstable disorder (e.g. cardiovascular, renal, hepatic disorder)
Description

Disease Uncontrolled | Disease Unstable | Cardiovascular Disease | Kidney Disease | Liver disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0443343
UMLS CUI [3]
C0007222
UMLS CUI [4]
C0022658
UMLS CUI [5]
C0023895
body mass index (bmi) of <17 or >40 kg>/m2
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
depressive symptoms, defined as a score of 9 or greater on the calgary depression rating scale for schizophrenia (cdss)
Description

Depressive Symptoms Depression scale Schizophrenia

Data type

boolean

Alias
UMLS CUI [1,1]
C0086132
UMLS CUI [1,2]
C0679604
UMLS CUI [1,3]
C0036341
a severity score of 3 or greater on the parkinsonism item of the esrs-a (clinical global impression, parkinsonism)
Description

ESRS-A - CGI-S Parkinsonism

Data type

boolean

Alias
UMLS CUI [1]
C3899303

Similar models

Eligibility Schizophrenia NCT01192880

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, aged 18 years and above
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Paranoid Schizophrenia | Schizophrenia, Disorganized | Residual schizophrenia | Undifferentiated schizophrenia | Schizophrenia, Catatonic
Item
diagnosis of schizophrenia of paranoid, disorganized, residual, undifferentiated or catatonic subtype
boolean
C0036349 (UMLS CUI [1])
C0036347 (UMLS CUI [2])
C0036351 (UMLS CUI [3])
C0392322 (UMLS CUI [4])
C0036344 (UMLS CUI [5])
Symptoms Negative Primary
Item
predominant negative symptoms
boolean
C1457887 (UMLS CUI [1,1])
C1513916 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
Exception Clozapine | Atypical antipsychotic Quantity | Typical Antipsychotic Quantity
Item
with the exception of clozapine, patients are on any of the available marketed atypical or typical antipsychotics (treatment with a maximum of two antipsychotics)
boolean
C1705847 (UMLS CUI [1,1])
C0009079 (UMLS CUI [1,2])
C1276996 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C2917392 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Disease Uncontrolled | Disease Unstable | Cardiovascular Disease | Kidney Disease | Liver disease
Item
evidence that patient has clinically significant, uncontrolled and unstable disorder (e.g. cardiovascular, renal, hepatic disorder)
boolean
C0012634 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0007222 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
Body mass index
Item
body mass index (bmi) of <17 or >40 kg>/m2
boolean
C1305855 (UMLS CUI [1])
Depressive Symptoms Depression scale Schizophrenia
Item
depressive symptoms, defined as a score of 9 or greater on the calgary depression rating scale for schizophrenia (cdss)
boolean
C0086132 (UMLS CUI [1,1])
C0679604 (UMLS CUI [1,2])
C0036341 (UMLS CUI [1,3])
ESRS-A - CGI-S Parkinsonism
Item
a severity score of 3 or greater on the parkinsonism item of the esrs-a (clinical global impression, parkinsonism)
boolean
C3899303 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial